Please assess the completion status of the following clinical trial:

Trial Title: Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged between 18 and 89 years old~* Patients with critical illness including ischemic or hemorrhagic stroke, epidural/subdural bleeds and subarachnoid hemorrhage~* Patients who are expected to stay in the ICU for at least 5 days~* Hyperglycemia is not an inclusion criteria~Exclusion Criteria:~* Patients who have received or will be treated with systemic corticosteroids.~* Patients who will be receiving high doses of propofol (\>40 cc/hr)~* Patients with type 1 Diabetes~* Patients with sepsis or acute trauma~* Patients with an expected stay in the ICU of less than 4 days~* Patients who are unable to receive enteral nutrition or who have medical conditions precluding nutrition by the enteral route including allergies to formula components~* Pregnant and lactating patients~* Patients with prior history of gastroparesis~* Patients with acute kidney failure (creatinine \> 2.5mg/dl)~* Patients with acute liver failure (bilirubin \> 2.0 mg/dl)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Glycerna (Type: EXPERIMENTAL): Diabetic specific formula. The volume /rate of glycerna will be determined by the dietician according to standard formula.
- Control - Jevity (Type: ACTIVE_COMPARATOR): The control arm of the study. Patients to receive Jevity. The volume /rate of Jevity will be determined by the dietician according to standard formula.

Based on this trial design, predict the completion outcome and termination type (if applicable).